Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Vera Therapeutics Inc. Class A Common Stock
VERA | US
37.69
USD-0.70
-1.82%
VERA | US
Loading StockChartView...
About Vera Therapeutics Inc. Class A Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
37.69
Open
38.21
High
39.31
Low
36.30
Vera Therapeutics Inc. a clinical stage biotechnology company focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868 a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair Inc. and changed its name to Vera Therapeutics Inc. in April 2020. Vera Therapeutics Inc. was incorporated in 2016 and is headquartered in Brisbane California.
View LessVERA | US
Risk
51.3
Sharpe
0.69
Luna's Score
40/100
Recommendation
Sell
Luna says (VERA | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
63.6%1 month
51.3%3 months
46.7%6 months
64.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
6.88
Debt to equity
0.16
Debt to assets
0.13
Ent. to EBITDA
-3.60
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-90.73M
MarketCap
2.07B
MarketCap(USD)
2.07B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-46.05
Short ratio
9.65
Short perc.
15.83
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
10.70
Range1M
10.70
Range3M
12.33
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.41
Price X volume
62.67M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.60 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 6.88 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 46.74 | 72.80 | Lower Risk |
| Debt to Equity | 0.16 | -1.23 | Expensive |
| Debt to Assets | 0.13 | 0.25 | Cheaper |
| Market Cap | 2.07B | 3.66B | Emerging |
